Research ArticleCanalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis
Graphical abstract
Introduction
Multidrug resistance-associated protein 2 (MRP2; ABCC2) is a member of the adenosine triphosphate (ATP)-binding cassette (ABC) transporter superfamily [1]. It is widely expressed in many human and rodent tissues, such as liver, kidney, intestine, brain, and breast [2], [3], [4]. MRP2/Mrp2 is localized on the apical membrane of epithelial cells in these tissues [1], [2], [3]. Specifically, it is expressed at the canalicular membrane of hepatocytes, the proximal tubule epithelial cells in kidney, and the brush-border membrane in small intestine for excreting conjugated organic anions, including bilirubin, bile acid divalent conjugates and drugs [1], [2]. In addition, MRP2/Mrp2 secretes glutathione into bile and is the major determinant of bile acid-independent bile flow [2]. Dysfunction of MRP2/Mrp2 leads to jaundice and hyperbilirubinemia in patients with Dubin-Johnson syndrome and in GY/TR− EHBR rats [3], [4]. Jaundice is also seen in patients with obstructive cholestasis. Hepatic MRP2 mRNA expression was not changed in these patients [5], [6], but how its protein expression is regulated remains uncertain.
Previous studies in cholestatic rodent models have found reduced hepatic Mrp2 protein expression without changes in mRNA expression [7], [8], [9], indicating that post-transcriptional regulation most likely plays an important role in regulating Mrp2 function. Indeed, loss of Mrp2 from bile canalicular membranes without altering its mRNA expression in Radixin knockout mice and Radixin knockdown rat hepatocytes emphasized the importance of Radixin in the expression and function of rodent Mrp2 at post-transcriptional levels [10], [11]. Radixin is a member of the Ezrin/Radixin/Moesin (ERM) protein family that consists of two more closely related proteins, i.e. Ezrin and Moesin [12]. ERM proteins are tether proteins, they connect certain plasma membrane proteins with actin filaments in cells [12]. The expression of individual ERM proteins varies in different tissues. Specifically, Radixin was abundantly expressed in rat hepatocytes, where Ezrin was undetectable by immunofluorescent labeling [13]. Instead, Ezrin was detected in biliary epithelia in the rat. Claperon et al. confirmed that Ezrin was mainly detected in bile duct epithelial cells in young children [14]. Interestingly, they also detected Ezrin at the canalicular membrane of hepatocytes in the livers of patients with biliary atresia and neonatal sclerosing cholangitis. Furthermore, both Ezrin and Radixin were detected in human hepatoma HepG2 and HuH7 cells [15], [16]. However, it is not known if Ezrin plays any role in MRP2 protein expression in human hepatocytes.
Studies from Caco2 cells and rat intestine tissue indicate that Ezrin regulates MRP2/Mrp2 membrane expression and function [17], [18], [19]. When the intestine was treated with the protein kinase C (PKC)-α specific activator Thymeleatoxin, Ezrin Thr567 phosphorylation, Mrp2 brush-border membrane expression and efflux activity were reduced although the mechanism remained unexplained [18]. In contrast, activation of PKCα stimulated Ezrin phosphorylation in human breast carcinoma cells (MCF-7 cells) [20]. Elevated PKC activity, including PKCα, δ, and ε, was also reported in cholestatic rodent liver [7], [21]. However, it remains to be determined if PKCs are involved in Ezrin phosphorylation in human cholestatic livers, and whether this process alters MRP2 expression and function.
In this report, we investigated the molecular mechanism of MRP2 expression regulation in the livers of patients with gallstone obstructive cholestasis. We found that hepatic MRP2 protein expression was significantly reduced in these patients. Immunoprecipitation identified Ezrin but not Radixin as the ERM protein that interacted with MRP2 in human livers. Phosphorylation of Ezrin positively correlated with its ability to associate with MRP2 protein but negatively correlated with the total amount of MRP2 protein expression. Further studies in HepG2 cells indicated that phosphorylation of Thr567 in Ezrin by PKCs reduced MRP2 membrane expression, whereas ubiquitin E3 GP78 controlled the degradation of internalized MRP2 in human hepatic cells. Our findings provide a novel mechanistic explanation for the pathogenesis of jaundice seen in patients with obstructive cholestasis and possibly other forms of cholestasis. Understanding the regulation of human MRP2 protein expression regulation may lead to new strategies for treating patients with various forms of hyperbilirubinemia.
Section snippets
Patients and liver samples collection
This research has been carried out in accordance with the Declaration of Helsinki (2008) of the World Medical Association, and has been approved by the Southwest Hospital Institutional Ethics Review Board (Chongqing, China). The corresponding written informed consent was obtained from all patients. Cholestatic liver samples (n = 30) were surgically resected from patients with obstruction by biliary stones originating from the intrahepatic bile duct and/or common bile duct within several days of
MRP2 protein expression and canalicular membrane localization were reduced in the livers of patients with obstructive cholestasis
Western blot analysis demonstrated that MRP2 protein expression in the membrane enriched fraction and whole liver lysate from obstructive cholestatic livers were significantly lower (only 25 ± 19% and 32 ± 27% respectively by setting control livers as 100%, p <0.01) than in the control livers (Fig. 1A; Supplementary Fig. 2), despite the lack of change in MRP2 mRNA as previously reported ([6] and data not shown). Both IHC and IF labeling further confirmed that MRP2 canalicular membrane expression in
Discussion
When jaundice develops in cholestatic patients, impaired function of MRP2 is thought to be the cause. Previous studies in rodent models of cholestasis have demonstrated translocation of Mrp2 from the canalicular membrane to the cytosol [28], [29]. Since hepatic MRP2 mRNA expression was not changed in patients with obstructive cholestasis [5], [6], post-transcriptional mechanisms are likely involved. As described in this report, MRP2 protein expression was significantly reduced in livers of
Financial support
This work was supported by National Natural Science Foundation of China (81170430, 81100280, 81470850, and 81470880), Scholarship Foundation of China Scholarship Council (CSC No. 201307610015) and Third Military Medical University (2013), and USPHS R37 DK 025636. S-YC and JLB were supported by NIH grants (DK34989 and DK25636).
Conflict of interest
The authors declare that there are no conflict of interests regarding the publication of this manuscript.
Acknowledgments
This work was supported by National Natural Science Foundation of China (81170430, 81070320, 81100280, and 81470880), Scholarship Foundation of China Scholarship Council (CSC No. 201307610015) and Third Military Medical University (2013). S.-Y.C and J.L.B were supported by NIH grants DK25636 and DK34989 (Yale Liver Center). We also thank Qiaobing Huang (Department of Pathophysiology, Key Lab for Shock and Microcirculation Research, Southern Medical University, Guangzhou, PR China) for Moesin
References (36)
- et al.
Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance
Biochim Biophys Acta
(1999) - et al.
New molecular insights into the mechanisms of cholestasis
J Hepatol
(2009) - et al.
Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome
Hepatology
(2002) - et al.
The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis
Gastroenterology
(1997) - et al.
Radixin is required to maintain apical canalicular membrane structure and function in rat hepatocytes
Gastroenterology
(2006) - et al.
Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia
Hepatology
(2001) - et al.
Immunohistochemical profile of ezrin and radixin in human liver epithelia during fetal development and pediatric cholestatic diseases
Clin Res Hepatol Gastroenterol
(2013) - et al.
Ezrin and radixin both regulate the apical membrane localization of ABCC2 (MRP2) in human intestinal epithelial Caco-2 cells
Exp Cell Res
(2007) - et al.
Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat
J Hepatol
(2004) - et al.
Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone
Gastroenterology
(1999)
Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes
Gastroenterology
Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis
J Biol Chem
Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene
Science
High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis
Hepatology
Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway
Hepatology
Ca(2+)-dependent protein kinase C isoforms are critical to estradiol 17beta-D-glucuronide-induced cholestasis in the rat
Hepatology
Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver
Hepatology
Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes
Nat Genet
Cited by (51)
Oligomerization of drug transporters: Forms, functions, and mechanisms
2024, Acta Pharmaceutica Sinica BTumor necrosis factor α upregulates the bile acid efflux transporter OATP3A1 via multiple signaling pathways in cholestasis
2022, Journal of Biological ChemistryCitation Excerpt :The impaired BA excretion and homeostasis results in cholestasis-related liver damage (1). In cholestasis, upregulation of BA efflux transporters, for example, MRP3 and OATP3A1 enhance BA elimination by hepatocytes (2–6). OATP3A1 deletion in mice aggravated BA accumulation and cholestatic liver injury, indicating that OATP3A1 has a pivotal role in cholestasis (6).
Sodium butyrate alleviates cholesterol gallstones by regulating bile acid metabolism
2021, European Journal of Pharmacology